Company
GSK PLC
LON:GSK
GSK PLC will be a fully focused biopharma company following the demerger of its world-leading consumer healthcare business, Haleon, in July 2022. The company will prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease.
746 stories · page 8 of 38
GSK falls victim to ‘hard to please’ pharma market
Modest future earnings per share growth may have deterred investors, Stifel said
Archive
FTSE 100 Live: Stocks close higher ahead of US rate call
The FTSE 100 index closed up 20.71 points, 0.3%, at 7,342.43 while the FTSE 250 ended up 102.84 points, 0.6%, at 17,185.89